{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T20:00:00Z","timestamp":1787169600062,"version":"build-2736575974"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,7]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Vitiligo is an acquired pigmentary disorder of the skin and mucous membranes which manifests as white macules and patches due to selective loss of melanocytes. This condition can affect the patients' psychology, leading to an impairment of quality of life (QOL). Recently, much attention is been given to the emotional and psychological issues in the affected subjects.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim of the Study:<\/jats:title>\n                    <jats:p>This was to assess the QOL impairment among Nigerian patients with vitiligo using a disease-specific quality of life index questionnaire (VitiQoL).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>Seventy seven adults aged 18 years and above with vitiligo attending the Dermatology Clinic of a tertiary health center were included in this cross-sectional study. The QOL was assessed using the vitiligo quality of life questionnaire (VitiQoL). Disease severity was assessed using Vitiligo Area Severity Index (VASI).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      The mean age of the study participants was 38.97 \u00b1 13.2 years, comprising of 32 (41.6%) and 45 (58.4%) females. Almost half of the vitiligo patients belong to the lower socioeconomic class, 37 (48.1%). The mean age of first onset of vitiligo was 33.5 \u00b1 14.84 years, with 32 (41.6%) of the participants having age of first onset between 24 and 42 years. The mean VitiQoL score was 30.51 \u00b1 15.74 (range 3\u201364). There was a significant relationship between VASI score and VitiQoL (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.036,\n                      <jats:italic toggle=\"yes\">r<\/jats:italic>\n                      = 0.517). Other factors such as age, gender, socioeconomic status, disease activity, family history of vitiligo, duration of the disease and educational attainment were significantly associated with VitiQoL score (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>QOL is impaired significantly in Nigerian patients with vitiligo. Focusing on patient's QOL is an essential aspect in the management of patients with vitiligo.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/npmj.npmj_579_21","type":"journal-article","created":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T13:55:58Z","timestamp":1634738158000},"page":"169-174","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["Quality of Life Impairment amongst Persons Living with Vitiligo using Disease Specific Vitiligo Quality of Life Index"],"prefix":"10.4103","volume":"28","author":[{"given":"Umar","family":"Abdullahi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tahir Turaki","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bolanle O. P.","family":"Musa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-3-20240908","first-page":"1","article-title":"Concise review of recent studies in vitiligo","volume":"2013","author":"Allam","year":"2013","journal-title":"Qatar Med J"},{"key":"R2-3-20240908","first-page":"192736","article-title":"Anti-thyroid peroxidase antibody in vitiligo: A prevalence study","volume":"5","author":"Dash","year":"2015","journal-title":"J Thyroid Res"},{"key":"R3-3-20240908","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1111\/j.1365-2702.2011.03777.x","article-title":"Investigating factors associated with depression of vitiligo patients in Singapore","volume":"21","author":"Chan","year":"2012","journal-title":"J Clin Nurs"},{"key":"R4-3-20240908","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s12955-016-0490-y","article-title":"Quality of life in patients with vitiligo: A cross-sectional study based on Vitiligo Quality of Life index (VitiQoL)","volume":"14","author":"Hedayat","year":"2016","journal-title":"Health Qual Life Outcomes"},{"key":"R5-3-20240908","first-page":"244","article-title":"Effect of vitiligo area scoring index on the quality of life in patients with vitiligo","volume":"32","author":"Hammam","year":"2019","journal-title":"Menoufia Med J"},{"key":"R6-3-20240908","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/j.1365-2230.1996.tb00116.x","article-title":"Factors affecting responses on dermatology life quality index items among vitiligo sufferers","volume":"21","author":"Kent","year":"1996","journal-title":"Clin Exp Dermatol"},{"key":"R7-3-20240908","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1046\/j.1468-3083.2002.00590.x","article-title":"Psychiatric morbidity in vitiligo: Prevalence and correlates in India","volume":"16","author":"Mattoo","year":"2002","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R8-3-20240908","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/j.1468-3083.2010.03808.x","article-title":"Health-related quality of life and marital quality of vitiligo patients in China","volume":"25","author":"Wang","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R9-3-20240908","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S0190-9622(86)70160-6","article-title":"Psychosocial effect of vitiligo: A comparison of vitiligo patients with \u201cnormal\u201d control subjects, with psoriasis patients, and with patients with other pigmentary disorders","volume":"15","author":"Porter","year":"1986","journal-title":"J Am Acad Dermatol"},{"key":"R10-3-20240908","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0190-9622(96)90112-7","article-title":"Psychologic effects of vitiligo: A critical incident analysis","volume":"35","author":"Kent","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"R11-3-20240908","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/1477-7525-1-58","article-title":"Quality of life in patients with vitiligo","volume":"1","author":"Parsad","year":"2003","journal-title":"Health Qual Life Outcomes"},{"key":"R12-3-20240908","first-page":"495","article-title":"Quality of life of vitiligo patients attending the University College Hospital Ibadan Nigeria","volume":"6","author":"Anaba","year":"2019","journal-title":"EJPMR"},{"key":"R13-3-20240908","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1016\/j.jaad.2012.01.038","article-title":"Development and validation of a vitiligo-specific quality-of-life instrument (VitiQoL)","volume":"69","author":"Lilly","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"R14-3-20240908","first-page":"111","article-title":"Socioeconomic and cultural background of hospitalised chidren in Ilesha","volume":"12","author":"Oyedeji","year":"1985","journal-title":"Niger J Paediatr"},{"key":"R15-3-20240908","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1111\/j.1755-148X.2012.00997.x","article-title":"Revised classification\/nomenclature of vitiligo and related issues: The vitiligo global issues consensus conference","volume":"25","author":"Ezzedine","year":"2012","journal-title":"Pigment Cell Melanoma Res"},{"key":"R16-3-20240908","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.jid.2015.12.040","article-title":"Development and validation of the Vitiligo Extent Score (VES): An international collaborative initiative","volume":"136","author":"van Geel","year":"2016","journal-title":"J Invest Dermatol"},{"key":"R17-3-20240908","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1001\/archderm.140.6.677","article-title":"Parametric modeling of narrowband UV-B phototherapy for vitiligo","volume":"140","author":"Hamzavi","year":"2004","journal-title":"Arch Dermatol"},{"key":"R18-3-20240908","doi-asserted-by":"crossref","first-page":"33","DOI":"10.4103\/0974-2077.79188","article-title":"Quality of life in Saudi vitiligo patients","volume":"4","author":"Al-Mubarak","year":"2011","journal-title":"J Cutan Aesthet Surg"},{"key":"R19-3-20240908","doi-asserted-by":"crossref","first-page":"700","DOI":"10.4103\/0378-6323.45141","article-title":"Life quality assessment among patients with vitiligo: Comparison of married and single patients in Iran","volume":"74","author":"Dolatshahi","year":"2008","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"R20-3-20240908","doi-asserted-by":"crossref","first-page":"104","DOI":"10.4103\/2349-5847.219684","article-title":"Quality of life in vitiligo: Relationship to clinical severity and demographic data","volume":"4","author":"Patvekar","year":"2017","journal-title":"Pigment Int"},{"key":"R21-3-20240908","doi-asserted-by":"crossref","first-page":"99","DOI":"10.4103\/0019-5154.174048","article-title":"Dermatology life quality index does not reflect quality of life status of Indian vitiligo patients","volume":"61","author":"Narahari","year":"2016","journal-title":"Indian J Dermatol"},{"key":"R22-3-20240908","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1471-5945-4-8","article-title":"DLQI scores in vitiligo: Reliability and validity of the Persian version","volume":"4","author":"Aghaei","year":"2004","journal-title":"BMC Dermatol"},{"key":"R23-3-20240908","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1365-2133.2009.09091.x","article-title":"Willingness-to-pay and life quality in patients with vitiligo","volume":"161","author":"Radtke","year":"2009","journal-title":"Br J Dermatol"},{"key":"R24-3-20240908","first-page":"YC01","article-title":"Dermatology specific quality of life in vitiligo patients and its relation with various variables: A hospital based cross-sectional study","volume":"8","author":"Mishra","year":"2014","journal-title":"J Clin Diagn Res"},{"key":"R25-3-20240908","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1111\/bjd.14640","article-title":"Non-segmental vitiligo disease duration and female sex are associated with comorbidity and disease extent: A retrospective analysis in 1307 patients aged=50 years","volume":"175","author":"Teulings","year":"2016","journal-title":"Br J Dermatol"},{"key":"R26-3-20240908","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/bjd.15560","article-title":"Factors affecting quality of life in patients with vitiligo: A nationwide study","volume":"178","author":"Bae","year":"2018","journal-title":"Br J Dermatol"},{"key":"R27-3-20240908","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/j.1468-3083.2009.03452.x","article-title":"Quality of life and psychological adaptation of Korean adolescents with vitiligo","volume":"24","author":"Choi","year":"2010","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R28-3-20240908","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1365-4632.2011.04932.x","article-title":"Quality of life among Malaysian patients with vitiligo","volume":"51","author":"Wong","year":"2012","journal-title":"Int J Dermatol"},{"key":"R29-3-20240908","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1111\/ijd.13198","article-title":"Quality of life in patients with vitiligo: An analysis of the dermatology life quality index outcome over the past two decades","volume":"55","author":"Amer","year":"2016","journal-title":"Int J Dermatol"},{"key":"R30-3-20240908","doi-asserted-by":"crossref","first-page":"e0210581","DOI":"10.1371\/journal.pone.0210581","article-title":"Quality of life of adult vitiligo patients using camouflage: A survey in a Chinese vitiligo community","volume":"14","author":"Chen","year":"2019","journal-title":"PLoS One"},{"key":"R31-3-20240908","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1111\/j.1365-2133.2005.06456.x","article-title":"Effect of vitiligo on self-reported health-related quality of life","volume":"152","author":"Ongenae","year":"2005","journal-title":"Br J Dermatol"},{"key":"R32-3-20240908","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1365-2133.2008.08678.x","article-title":"Identification of categories at risk for high quality of life impairment in patients with vitiligo","volume":"159","author":"Sampogna","year":"2008","journal-title":"Br J Dermatol"}],"container-title":["Nigerian Postgraduate Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/npmj.npmj_579_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:09:39Z","timestamp":1787166579000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/npmj.npmj_579_21"}},"subtitle":["A Nigerian Perspective"],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.4103\/npmj.npmj_579_21","relation":{},"ISSN":["1117-1936"],"issn-type":[{"value":"1117-1936","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]}}}